Literature DB >> 11169410

The proteasome regulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition.

K Schwarz1, M Eggers, A Soza, U H Koszinowski, P M Kloetzel, M Groettrup.   

Abstract

PA28alpha/beta is a regulatory complex of the 20S proteasome which consists of two IFN-gamma inducible subunits. Both subunits, alpha and beta, contribute equally to the formation of hexa- or heptameric rings which can associate with the 20S proteasome. Previously, we have shown that overexpression of the PA28alpha subunit enhanced the MHC class I-restricted presentation of two viral epitopes and that purified PA28alpha/beta accelerated T cell epitope generation by the 20S proteasome in vitro, indicating a role for PA28alpha/beta in antigen presentation. This conclusion was recently confirmed in PA28beta gene targeted mice which were severely deficient in MHC class I-restricted antigen presentation. These mice displayed a defect in the assembly of immunoproteasomes, suggesting that a lack of the proteasome subunits LMP2, LMP7, and MECL-1 may account for the deficiency in antigen presentation. In this study we investigated whether the effect of PA28alpha/beta on antigen presentation is dependent on a change of proteasome subunit composition. We have analyzed the assembly and subunit composition of proteasomes in fibroblast transfectants overexpressing both, alpha and beta subunits of PA28. In these transfectants we found a marked enhancement in the presentation of the immunodominant H-2Ld-restricted pp89 epitope of murine cytomegalovirus, although the 20S proteasome composition was the same as in recipient cells. We, therefore, conclude that PA28alpha/beta can enhance antigen processing independently of changes in 20S proteasome subunit composition or assembly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11169410     DOI: 10.1002/1521-4141(200012)30:12<3672::AID-IMMU3672>3.0.CO;2-B

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.

Authors:  Rafaela Holtappels; Doris Thomas; Jürgen Podlech; Matthias J Reddehase
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 2.  Proteasome activator 200: the heat is on...

Authors:  Anca F Savulescu; Michael H Glickman
Journal:  Mol Cell Proteomics       Date:  2011-03-09       Impact factor: 5.911

Review 3.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

4.  Simultaneous EGFP and tag labeling of the β7 subunit for live imaging and affinity purification of functional human proteasomes.

Authors:  Valentina A Kulichkova; Tatiana O Artamonova; Julia J Zaykova; Julia B Ermolaeva; Mikhail A Khodorkovskii; Nikolai A Barlev; Alexey N Tomilin; Anna S Tsimokha
Journal:  Mol Biotechnol       Date:  2015-01       Impact factor: 2.695

5.  Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta.

Authors:  S Murata; H Udono; N Tanahashi; N Hamada; K Watanabe; K Adachi; T Yamano; K Yui; N Kobayashi; M Kasahara; K Tanaka; T Chiba
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

6.  Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome.

Authors:  Michael Basler; Elmer Maurits; Gerjan de Bruin; Julia Koerner; Herman S Overkleeft; Marcus Groettrup
Journal:  Br J Pharmacol       Date:  2017-11-29       Impact factor: 8.739

7.  A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction.

Authors:  Selina Khan; Albert Zimmermann; Michael Basler; Marcus Groettrup; Hartmut Hengel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 8.  The role of the proteasome in the generation of MHC class I ligands and immune responses.

Authors:  E J A M Sijts; P M Kloetzel
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

9.  The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation.

Authors:  Frédéric Ebstein; Andrea Lehmann; Peter-Michael Kloetzel
Journal:  Cell Mol Life Sci       Date:  2012-02-19       Impact factor: 9.261

10.  Deciphering preferential interactions within supramolecular protein complexes: the proteasome case.

Authors:  Bertrand Fabre; Thomas Lambour; Luc Garrigues; François Amalric; Nathalie Vigneron; Thomas Menneteau; Alexandre Stella; Bernard Monsarrat; Benoît Van den Eynde; Odile Burlet-Schiltz; Marie-Pierre Bousquet-Dubouch
Journal:  Mol Syst Biol       Date:  2015-01-05       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.